Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use
- 22 Downloads
When cardiologists diagnose patients with coronary spastic angina, Japanese Circulation Society (JCS) guidelines recommend the intracoronary injection of acetylcholine (ACh) and ergonovine (ER) as class I. However, the pharmacological difference between ACh and ER is controversial in the clinic. We performed both ACh and ER tests in the same 528 patients during 26 years. We investigated the provoked spasm configuration, spasm site, and clinical characteristics of provoked spasm between ACh and ER, retrospectively. We defined positive spasm as ≥90% luminal narrowing. Provoked positive spasm was observed in 161 right coronary arteries (RCA) including 83 ACh just positive, 35 ER just positive, and 43 both positive. In contrast, positive spasm was documented in 172 left coronary arteries (LCA) including 94 ACh just positive, 28 ER just positive, and 50 both positive. ACh provoked spasm more distally and diffusely, while ER induced spasm more proximally and totally or focally in the RCA. In the LCA, ACh provoked spasm more proximally, whereas ER induced spasm more distally. ER testing after the negative ACh tests of RCA and LCA documented new positive spasms in 10.3% (35/340) and 7.4% (28/376), respectively. Coronary artery trees may each have a sensitive receptor on each segment. We recommend the supplementary use of ACh and ER to document coronary artery spasm in the cardiac catheterization laboratory.
KeywordsPositive spasm Acetylcholine Ergonovine Supplementary use
We acknowledge the helpful comments of Professor Osamu Yamaguchi, MD, Professor Yuji Shigematsu, MD, Professor Mareomi Hamada, MD, Professor Jitsuo Higaki, MD and Professor Kunio Hiwada, MD.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 2.Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H, Bairey Merz CN (2017) Coronary Vasomotor Disorders International Study Group (COVADIS). International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 38:2565–2568Google Scholar
- 3.Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology Eur Heart J 34:2949–3003 (published correction appears in Eur Heart J 35: 2260-2261) Google Scholar
- 4.Anderson JI, Adams CD, Antman EM, Bridges CR, Califf RM, Casey Jr DE, Chavey II WE, Fesmire FM, Hochman JS, Levin TN, Lincoff M, Peterson ED, Theroux P, Wenger NK, Wright S (2013) 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127:e663–e828 (published correction appears in Circulation. 2013; 127:e863–e864) Google Scholar
- 14.Scanlon PJ, Faxon DP, Audet AM, Leon DL, Carabello B, Murray JA, Dehmer GJ, Nissen SE, Eagle KA, Pepine CJ, Legako RD, Watson RM. Ritchie JL, Gibbons RJ, Chettlin MD, Russell RO, Eagle KA, Ryan TJ, Gardner TJ, Smith Jr SC, Garson Jr AG (1999) ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol 33:1756–1824Google Scholar
- 21.Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T (1986) Induction of coronary artery spasm by acetylcholine in patients with variant angina : possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74:955–963CrossRefGoogle Scholar
- 23.Sueda S, Ochi T, Yano K, Mineoi K, Kondou T, Ochi N, Hayashi Y, Kukita H, Matsuda S, Kawada H, Tsuruoka T, Uraoka T (2000) New combined spasm provocation test in patients with rest angina: Intracoronary injection of acetylcholine after intracoronary administration of ergonovine. Jpn Circ J 64:559–565CrossRefGoogle Scholar
- 19.Harding MB, Leithe ME, Mark DB, Nelson CL, Harrison JK, Hermiller JB, Davidson CJ, Pryor DB, Bashore TM (1992) Ergonovine maleate testing during cardiac catheterization: A 10-year perspective in 3447 patients without significant coronary artery disease or Prinzmetal’s variant angina. J Am Coll Cardiol 20:107–111CrossRefGoogle Scholar
- 20.Ong P, Athanasiadis A, Borgulya G, Voksi I, Bastiaenen R, Kubik S, Hill S, Schaufele T, Mahrholdt H, Kaski JC, Sechtem U (2014) Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 129:1723–1730CrossRefGoogle Scholar